Calyxt, Inc. (CLXT) NASDAQ
$6.30 0.33 (5.53%)
Market Cap: $31.33M
As of 05/31/23 04:00 PM EDT. Market closed.
Calyxt, Inc. (CLXT)
NASDAQ
$6.30
0.33 (5.53%)
Market Cap: $31.33M
As of 05/31/23 04:00 PM EDT. Market closed.
Add to Portfolio
Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company for the exclusive license of an improved quality alfalfa seed in the ... read more
COMPANY PROFILE
Sector
Consumer Defensive
Industry
Packaged Foods
CEO
Mr. Michael Allen Carr
Full Time Employees
48
CEO Compensation (Base)
$500,000
CEO Compensation (Total)
$1.51M
Sector
Consumer Defensive
Industry
Packaged Foods
CEO
Mr. Michael Allen Carr
Full Time Employees
48
CEO Compensation (Base)
$500,000
CEO Compensation (Total)
$1.51M
URL
Address
2800 Mount Ridge Road, MN, Roseville, 55113-1127.
PRICE CHART FOR CALYXT, INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$6.16
Previous Close
$5.97
Days Range
$6.01 - $7.77
52 week range
$6.01 - $38.85
Volume
254,088
Avg. Volume (30 days)
22,518
Market Cap
$31.33M
Dividend Yield
-
P/E
(1.64)
Shares Outstanding
4,973,690
Open
$6.16
Previous Close
$5.97
Days Range
$6.01 - $7.77
52 week range
$6.01 - $38.85
Volume
254,088
Avg. Volume (30 days)
22,518
Market Cap
$31.33M
Dividend Yield
-
P/E
(1.64)
Shares Outstanding
4,973,690
FINANCIAL STATEMENTS FOR CALYXT, INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR CALYXT, INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Gocal Gregory Francis William | Chief Scientific Officer & EVP | Jul 15, 2024 | Sale | $10.01 | 2,000 | 20,023 | 314,844 | Jul 17, 2024, 04:10 PM |
| Gocal Gregory Francis William | Chief Scientific Officer & EVP | Jul 12, 2024 | Sale | $10.00 | 2,000 | 20,000 | 316,844 | Jul 15, 2024, 05:07 PM |
| Gocal Gregory Francis William | Chief Scientific Officer & EVP | Jun 27, 2024 | Sale | $10.00 | 2,000 | 20,000 | 318,844 | Jul 15, 2024, 05:03 PM |
| RIGGS RORY B | Chief Executive Officer | Jun 11, 2024 | Option Exercise | $10.20 | 98,040 | 1,000,008 | 3,201,828 | Jun 14, 2024, 06:53 AM |
| RIGGS RORY B | Chief Executive Officer | Dec 12, 2023 | Buy | $10.58 | 517,107 | 5,470,992 | 1,622,495 | Dec 14, 2023, 05:10 PM |
| RIGGS RORY B | Chief Executive Officer | Jun 01, 2023 | Buy | $31.50 | 1,000 | 31,500 | 1,154,464 | Jun 02, 2023, 07:05 AM |
| Koschak William | Chief Financial Officer | Mar 27, 2023 | Option Exercise | $0.34 | 11,967 | 4,069 | 669,590 | Mar 29, 2023, 04:17 PM |
| Frimerman Debra H | General Counsel and Secretary | Mar 27, 2023 | Option Exercise | $0.34 | 11,967 | 4,069 | 661,902 | Mar 29, 2023, 04:14 PM |
| Frey Travis | Chief Technology Officer | Mar 27, 2023 | Option Exercise | $0.34 | 11,967 | 4,069 | 666,327 | Mar 29, 2023, 04:11 PM |
| Carr Michael A. | President and CEO | Mar 27, 2023 | Option Exercise | $0.34 | 16,025 | 5,449 | 882,011 | Mar 29, 2023, 04:08 PM |
| Frimerman Debra H | General Counsel and Secretary | Mar 14, 2023 | Option Exercise | $0.31 | 2,621 | 813 | 673,869 | Mar 16, 2023, 04:43 PM |
| Koschak William | Chief Financial Officer | Mar 14, 2023 | Option Exercise | $0.31 | 2,483 | 770 | 681,557 | Mar 16, 2023, 04:40 PM |
| Frey Travis | Chief Technology Officer | Mar 14, 2023 | Option Exercise | $0.31 | 2,276 | 706 | 678,294 | Mar 16, 2023, 04:36 PM |
| Carr Michael A. | President and CEO | Mar 07, 2023 | Option Exercise | $0.43 | 20,261 | 8,714 | 898,036 | Mar 08, 2023, 04:15 PM |
| Frey Travis | Chief Technology Officer | Mar 07, 2023 | Option Exercise | $0.43 | 11,967 | 5,147 | 680,570 | Mar 08, 2023, 04:13 PM |
| Frimerman Debra H | General Counsel and Secretary | Mar 07, 2023 | Option Exercise | $0.43 | 11,967 | 5,147 | 676,490 | Mar 08, 2023, 04:11 PM |
| Koschak William | Chief Financial Officer | Mar 07, 2023 | Option Exercise | $0.43 | 11,967 | 5,147 | 684,040 | Mar 08, 2023, 04:08 PM |
| Carr Michael A. | President and CEO | Jan 01, 2023 | Option Exercise | $0.15 | 47,877 | 7,062 | 376,064 | Jan 04, 2023, 04:44 PM |
| Frey Travis | Chief Technology Officer | Jan 01, 2023 | Option Exercise | $0.15 | 37,573 | 5,542 | 185,304 | Jan 04, 2023, 04:41 PM |
| Frimerman Debra H | General Counsel and Secretary | Jan 01, 2023 | Option Exercise | $0.15 | 35,724 | 5,269 | 181,224 | Jan 04, 2023, 04:38 PM |
| Koschak William | Chief Financial Officer | Jan 01, 2023 | Option Exercise | $0.15 | 42,570 | 6,279 | 212,525 | Jan 04, 2023, 04:35 PM |
| Ribeill Yves J | Director | Sep 19, 2022 | Sale | $0.24 | 30,000 | 7,173 | 99,225 | Sep 20, 2022, 04:09 PM |
| Carr Michael A. | President and CEO | Jul 27, 2022 | Option Exercise | $0.22 | 4,059 | 893 | 423,941 | Jul 28, 2022, 05:18 PM |
| Ribeill Yves J | Director | Mar 21, 2022 | Sale | $1.06 | 20,000 | 21,238 | 129,225 | Mar 22, 2022, 04:09 PM |
| Frey Travis | Chief Technology Officer | Mar 14, 2022 | Option Exercise | $1.08 | 2,173 | 2,347 | 17,227 | Mar 16, 2022, 06:26 PM |
| Frimerman Debra H | General Counsel and Secretary | Mar 14, 2022 | Option Exercise | $1.08 | 2,502 | 2,702 | 16,498 | Mar 16, 2022, 06:23 PM |
| Koschak William | Chief Financial Officer | Mar 14, 2022 | Option Exercise | $1.05 | 2,605 | 2,740 | 35,395 | Mar 16, 2022, 06:19 PM |
| Carr Michael A. | President and CEO | Aug 30, 2021 | Buy | $3.98 | 10,000 | 39,776 | 60,000 | Aug 31, 2021, 04:53 PM |
| Koschak William | Chief Financial Officer | Aug 19, 2021 | Buy | $3.21 | 20,000 | 64,112 | 38,000 | Aug 23, 2021, 04:31 PM |
| Ribeill Yves J | Executive Chair | Jul 27, 2021 | Option Exercise | $3.65 | 50,429 | 184,066 | 149,225 | Jul 28, 2021, 05:23 PM |
| Carr Michael A. | President and CEO | Jul 27, 2021 | Option Exercise | $3.65 | 50,000 | 182,500 | 50,000 | Jul 28, 2021, 05:18 PM |
| Ribeill Yves J | Executive Chair | Jul 01, 2021 | Option Exercise | $4.07 | 12,048 | 49,035 | 98,796 | Jul 06, 2021, 04:59 PM |
| Dumont Philippe | Director | Jul 18, 2019 | Sale | $10.00 | 706 | 7,060 | 16,354 | Jun 01, 2021, 05:19 PM |
| Voytas Daniel F | Chief Science Officer | Jan 04, 2021 | Sale | $4.13 | 2,513 | 10,388 | 0 | Jan 05, 2021, 05:11 PM |
| Blome James | Chief Executive Officer | Dec 31, 2020 | Sale | $4.17 | 4,140 | 17,281 | 186,282 | Jan 04, 2021, 05:12 PM |
| Voytas Daniel F | Chief Science Officer | Dec 18, 2020 | Sale | $4.75 | 5,026 | 23,874 | 2,513 | Dec 21, 2020, 05:08 PM |
| Frey Travis | Chief Technology Officer | Dec 01, 2020 | Buy | $3.79 | 150 | 569 | 2,900 | Dec 02, 2020, 05:10 PM |
| Frey Travis | Chief Technology Officer | Nov 02, 2020 | Buy | $3.26 | 150 | 489 | 2,750 | Nov 04, 2020, 06:44 PM |
| Cellectis S.A. | 10% Owner | Oct 16, 2020 | Option Exercise | $4.00 | 1,250,000 | 5,000,000 | 23,963,175 | Oct 20, 2020, 06:05 AM |
| Frey Travis | Chief Technology Officer | Oct 01, 2020 | Buy | $5.47 | 150 | 820 | 2,600 | Oct 02, 2020, 05:57 PM |
| Blome James | Chief Executive Officer | Sep 30, 2020 | Sale | $5.59 | 4,140 | 23,124 | 190,422 | Oct 01, 2020, 05:09 PM |
| Dumont Philippe | Director | Sep 10, 2020 | Buy | $5.91 | 3,000 | 17,729 | 6,290 | Sep 11, 2020, 05:06 PM |
| Frey Travis | Chief Technology Officer | Sep 01, 2020 | Buy | $5.41 | 150 | 811 | 2,450 | Sep 01, 2020, 05:10 PM |
| Kozicz-Stankiewicz Anna Ewa | Director | Jul 02, 2020 | Sale | $4.70 | 245 | 1,151 | 3,165 | Aug 21, 2020, 05:20 PM |
| Kozicz-Stankiewicz Anna Ewa | Director | Apr 02, 2020 | Sale | $2.87 | 245 | 703 | 3,410 | Aug 21, 2020, 05:20 PM |
| Dumont Philippe | Director | Aug 14, 2020 | Buy | $7.49 | 2,000 | 14,970 | 3,290 | Aug 21, 2020, 05:16 PM |
| Dumont Philippe | Director | Jul 02, 2020 | Sale | $4.70 | 236 | 1,109 | 1,290 | Aug 21, 2020, 05:16 PM |
| Dumont Philippe | Director | Apr 02, 2020 | Sale | $2.87 | 236 | 677 | 1,526 | Aug 21, 2020, 05:16 PM |
| Choulika Andre | Director | Jul 01, 2020 | Sale | $4.65 | 4,228 | 19,647 | 130,815 | Aug 03, 2020, 05:13 PM |
| Frey Travis | Chief Technology Officer | Aug 03, 2020 | Buy | $4.36 | 150 | 654 | 2,300 | Aug 03, 2020, 05:07 PM |
| Blome James | Chief Executive Officer | Jul 01, 2020 | Sale | $4.65 | 3,495 | 16,268 | 194,562 | Jul 31, 2020, 05:12 PM |
| Blome James | Chief Executive Officer | Jun 29, 2020 | Sale | $5.01 | 2,902 | 14,532 | 198,057 | Jul 31, 2020, 05:12 PM |
| Frey Travis | Chief Technology Officer | Jul 01, 2020 | Buy | $5.04 | 156 | 786 | 2,150 | Jul 01, 2020, 04:40 PM |
| Frey Travis | Chief Technology Officer | Jun 01, 2020 | Buy | $4.43 | 144 | 638 | 1,994 | Jun 02, 2020, 04:26 PM |
| Frey Travis | Chief Technology Officer | May 01, 2020 | Buy | $4.32 | 175 | 755 | 1,850 | May 04, 2020, 02:34 PM |
| Choulika Andre | Director | Mar 31, 2020 | Option Exercise | $2.95 | 3,690 | 10,903 | 135,043 | Apr 02, 2020, 04:23 PM |
| Blome James | Chief Executive Officer | Mar 31, 2020 | Option Exercise | $2.96 | 3,177 | 9,389 | 200,959 | Apr 02, 2020, 04:21 PM |
| Frey Travis | Chief Technology Officer | Apr 01, 2020 | Buy | $3.19 | 175 | 559 | 1,675 | Apr 01, 2020, 04:30 PM |
| Frey Travis | Chief Technology Officer | Mar 02, 2020 | Buy | $6.43 | 200 | 1,286 | 1,500 | Mar 04, 2020, 04:12 PM |
| Ribeill Yves J | Director | Feb 28, 2020 | Sale | $5.46 | 9,990 | 54,520 | 38,320 | Mar 02, 2020, 10:45 AM |
| Frey Travis | Chief Technology Officer | Feb 03, 2020 | Buy | $5.61 | 200 | 1,122 | 1,300 | Feb 04, 2020, 08:40 AM |
| Frey Travis | Chief Technology Officer | Jan 15, 2020 | Buy | $7.89 | 275 | 2,170 | 1,100 | Jan 17, 2020, 03:12 PM |
| Frey Travis | Chief Technology Officer | Jan 14, 2020 | Buy | $7.24 | 275 | 1,990 | 825 | Jan 14, 2020, 02:05 PM |
| Frey Travis | Chief Technology Officer | Jan 13, 2020 | Buy | $7.19 | 275 | 1,977 | 550 | Jan 14, 2020, 02:05 PM |
| Frey Travis | Chief Technology Officer | Jan 10, 2020 | Buy | $7.64 | 275 | 2,101 | 275 | Jan 13, 2020, 10:38 AM |
| Dumont Philippe | Director | Jan 03, 2020 | Sale | $7.60 | 236 | 1,794 | 1,762 | Jan 07, 2020, 07:37 PM |
| Kozicz-Stankiewicz Anna Ewa | Director | Jan 03, 2020 | Sale | $7.65 | 245 | 1,874 | 3,655 | Jan 07, 2020, 07:32 PM |
| Dumont Philippe | Director | Oct 02, 2019 | Sale | $4.96 | 236 | 1,171 | 1,998 | Oct 03, 2019, 01:46 PM |
| Kozicz-Stankiewicz Anna Ewa | Director | Oct 02, 2019 | Sale | $4.96 | 245 | 1,215 | 3,900 | Oct 03, 2019, 01:43 PM |
| Kozicz-Stankiewicz Anna Ewa | Director | Jul 18, 2019 | Sale | $10.00 | 735 | 7,350 | 4,145 | Jul 22, 2019, 11:30 AM |
| Dumont Philippe | Director | Jul 18, 2019 | Sale | $10.00 | 706 | 7,060 | 2,234 | Jul 22, 2019, 11:17 AM |
| Sahoo Manoj | Chief Commercial Officer | Jul 01, 2019 | Sale | $12.70 | 1,494 | 18,967 | 65,323 | Jul 02, 2019, 01:20 PM |
| Choulika Andre | Director | Jun 14, 2019 | Option Exercise | $12.90 | 15,715 | 202,723 | 138,733 | Jun 18, 2019, 05:22 PM |
| Voytas Daniel F | Chief Science Officer | Apr 29, 2019 | Option Exercise | $3.59 | 3,750 | 13,462 | 96,732 | Apr 30, 2019, 04:26 PM |
| Voytas Daniel F | Chief Science Officer | Apr 29, 2019 | Sale | $16.31 | 3,750 | 61,152 | 92,982 | Apr 30, 2019, 04:26 PM |
| Blome James | Chief Executive Officer | Apr 02, 2019 | Sale | $16.65 | 2,582 | 42,982 | 154,136 | Apr 04, 2019, 04:07 PM |
| Sahoo Manoj | Chief Commercial Officer | Apr 01, 2019 | Sale | $17.33 | 1,522 | 26,378 | 66,817 | Apr 02, 2019, 08:38 AM |
| Blome James | Chief Executive Officer | Mar 26, 2019 | Sale | $17.87 | 2,582 | 46,129 | 156,718 | Mar 27, 2019, 04:22 PM |
| Sahoo Manoj | Chief Commercial Officer | Mar 20, 2019 | Sale | $18.00 | 3,262 | 58,716 | 68,339 | Mar 21, 2019, 04:07 PM |
| Sahoo Manoj | Chief Commercial Officer | Mar 19, 2019 | Sale | $18.00 | 5,068 | 91,224 | 71,601 | Mar 21, 2019, 04:07 PM |
| Blome James | Chief Executive Officer | Mar 19, 2019 | Sale | $17.32 | 2,582 | 44,713 | 159,300 | Mar 20, 2019, 09:26 PM |
| Blome James | Chief Executive Officer | Mar 12, 2019 | Sale | $16.58 | 2,582 | 42,802 | 161,882 | Mar 15, 2019, 04:03 PM |
| Ribeill Yves J | Director | Mar 14, 2019 | Sale | $16.33 | 4,980 | 81,317 | 40,020 | Mar 15, 2019, 04:01 PM |
| Ribeill Yves J | Director | Mar 13, 2019 | Sale | $16.08 | 5,000 | 80,410 | 45,000 | Mar 15, 2019, 04:01 PM |
| Ribeill Yves J | Director | Mar 12, 2019 | Sale | $16.76 | 5,000 | 83,819 | 50,000 | Mar 15, 2019, 04:01 PM |
| Ribeill Yves J | Director | Mar 11, 2019 | Sale | $17.39 | 5,000 | 86,958 | 55,000 | Mar 15, 2019, 04:01 PM |
| Voytas Daniel F | Chief Science Officer | Feb 25, 2019 | Option Exercise | $3.59 | 3,977 | 14,277 | 96,959 | Feb 26, 2019, 06:44 PM |
| Voytas Daniel F | Chief Science Officer | Feb 25, 2019 | Sale | $16.00 | 3,977 | 63,632 | 92,982 | Feb 26, 2019, 06:44 PM |
| Voytas Daniel F | Chief Science Officer | Feb 01, 2019 | Option Exercise | $3.71 | 4,087 | 15,180 | 97,069 | Feb 04, 2019, 05:41 PM |
| Voytas Daniel F | Chief Science Officer | Jan 31, 2019 | Option Exercise | $3.71 | 4,083 | 15,165 | 97,065 | Feb 04, 2019, 05:41 PM |
| Voytas Daniel F | Chief Science Officer | Feb 01, 2019 | Sale | $13.00 | 4,087 | 53,131 | 92,982 | Feb 04, 2019, 05:41 PM |
| Voytas Daniel F | Chief Science Officer | Jan 31, 2019 | Sale | $13.00 | 4,083 | 53,079 | 92,982 | Feb 04, 2019, 05:41 PM |
| Dumont Philippe | Director | Jan 04, 2019 | Sale | $12.00 | 1,117 | 13,404 | 17,060 | Jan 08, 2019, 04:09 PM |
| Sahoo Manoj | Chief Commercial Officer | Jan 02, 2019 | Sale | $10.39 | 2,444 | 25,389 | 76,669 | Jan 04, 2019, 04:03 PM |
| Voytas Daniel F | Chief Science Officer | Dec 18, 2018 | Option Exercise | $3.71 | 4,083 | 15,165 | 97,065 | Dec 20, 2018, 04:16 PM |
| Voytas Daniel F | Chief Science Officer | Dec 18, 2018 | Sale | $13.00 | 4,083 | 53,079 | 92,982 | Dec 20, 2018, 04:16 PM |
| Voytas Daniel F | Chief Science Officer | Nov 08, 2018 | Option Exercise | $3.71 | 4,083 | 15,165 | 97,065 | Nov 13, 2018, 12:00 AM |
| Voytas Daniel F | Chief Science Officer | Nov 08, 2018 | Sale | $13.00 | 4,083 | 53,079 | 92,982 | Nov 13, 2018, 12:00 AM |
| Voytas Daniel F | Chief Science Officer | Oct 09, 2018 | Option Exercise | $3.71 | 4,083 | 15,165 | 97,065 | Oct 11, 2018, 04:04 PM |
| Voytas Daniel F | Chief Science Officer | Oct 09, 2018 | Sale | $13.84 | 4,083 | 56,514 | 92,982 | Oct 11, 2018, 04:04 PM |
| Dumont Philippe | Director | Oct 05, 2018 | Sale | $14.11 | 1,117 | 15,765 | 18,177 | Oct 09, 2018, 04:14 PM |
| Sahoo Manoj | Chief Commercial Officer | Oct 01, 2018 | Sale | $14.84 | 2,521 | 37,416 | 79,113 | Oct 03, 2018, 06:25 PM |
| Voytas Daniel F | Chief Science Officer | Sep 20, 2018 | Option Exercise | $3.59 | 4,666 | 16,751 | 97,648 | Sep 21, 2018, 04:09 PM |
| Voytas Daniel F | Chief Science Officer | Sep 20, 2018 | Sale | $16.00 | 4,666 | 74,656 | 92,982 | Sep 21, 2018, 04:09 PM |
| Voytas Daniel F | Chief Science Officer | Aug 20, 2018 | Option Exercise | $3.59 | 4,666 | 16,751 | 97,648 | Aug 22, 2018, 04:58 PM |
| Voytas Daniel F | Chief Science Officer | Aug 20, 2018 | Sale | $17.31 | 4,666 | 80,768 | 92,982 | Aug 22, 2018, 04:58 PM |
| Voytas Daniel F | Chief Science Officer | Aug 08, 2018 | Option Exercise | $3.71 | 4,083 | 15,165 | 97,065 | Aug 10, 2018, 02:22 PM |
| Voytas Daniel F | Chief Science Officer | Aug 08, 2018 | Sale | $17.48 | 4,083 | 71,372 | 92,982 | Aug 10, 2018, 02:22 PM |
| Voytas Daniel F | Chief Science Officer | Jul 20, 2018 | Option Exercise | $3.59 | 4,666 | 16,751 | 97,648 | Jul 24, 2018, 08:20 PM |
| Voytas Daniel F | Chief Science Officer | Jul 20, 2018 | Sale | $17.94 | 4,666 | 83,708 | 92,982 | Jul 24, 2018, 08:20 PM |
| Voytas Daniel F | Chief Science Officer | Jul 20, 2018 | Option Exercise | $3.59 | 4,666 | 16,751 | 97,648 | Jul 24, 2018, 08:03 PM |
| Voytas Daniel F | Chief Science Officer | Jul 20, 2018 | Sale | $17.94 | 4,666 | 83,708 | 92,982 | Jul 24, 2018, 08:03 PM |
| Voytas Daniel F | Chief Science Officer | Jul 09, 2018 | Option Exercise | $3.71 | 4,083 | 15,165 | 97,065 | Jul 11, 2018, 04:08 PM |
| Voytas Daniel F | Chief Science Officer | Jul 09, 2018 | Sale | $17.84 | 4,083 | 72,822 | 92,982 | Jul 11, 2018, 04:08 PM |
| Godard Alain | Director | Jun 21, 2018 | Sale | $20.84 | 5,880 | 122,540 | 33,320 | Jun 25, 2018, 02:57 PM |
| Voytas Daniel F | Chief Science Officer | Jun 20, 2018 | Option Exercise | $3.59 | 4,666 | 16,751 | 97,648 | Jun 22, 2018, 03:53 PM |
| Voytas Daniel F | Chief Science Officer | Jun 20, 2018 | Sale | $20.56 | 4,666 | 95,910 | 92,982 | Jun 22, 2018, 03:53 PM |
| Arbadji Michel | Director of Business Developme | Jun 20, 2018 | Option Exercise | $3.59 | 6,500 | 23,321 | 31,490 | Jun 22, 2018, 03:49 PM |
| Arbadji Michel | Director of Business Developme | Jun 20, 2018 | Sale | $22.00 | 6,500 | 143,000 | 24,990 | Jun 22, 2018, 03:49 PM |
| Sahoo Manoj | Chief Commercial Officer | Jun 18, 2018 | Sale | $20.51 | 490 | 10,050 | 81,634 | Jun 19, 2018, 03:08 PM |
| Corkal Bryan W.J. | Chief Financial Officer | Jun 15, 2018 | Sale | $18.77 | 5,093 | 95,613 | 73,307 | Jun 18, 2018, 03:54 PM |
| Arbadji Michel | Director of Business Developme | Jun 15, 2018 | Sale | $18.75 | 4,410 | 82,706 | 24,990 | Jun 18, 2018, 03:43 PM |
| Voytas Daniel F | Chief Science Officer | Jun 15, 2018 | Sale | $19.49 | 7,539 | 146,935 | 92,982 | Jun 15, 2018, 06:31 PM |
| Tripodi Federico A. | Chief Executive Officer | Jun 15, 2018 | Sale | $19.49 | 14,700 | 286,503 | 181,300 | Jun 15, 2018, 06:28 PM |
| Sahoo Manoj | Chief Commercial Officer | Jun 15, 2018 | Sale | $19.49 | 5,096 | 99,321 | 82,124 | Jun 15, 2018, 06:22 PM |
| Kozicz-Stankiewicz Anna Ewa | Director | Jun 15, 2018 | Sale | $19.49 | 1,000 | 19,490 | 18,600 | Jun 15, 2018, 06:19 PM |
| Dumont Philippe | Director | Jun 15, 2018 | Sale | $19.49 | 706 | 13,760 | 19,294 | Jun 15, 2018, 06:15 PM |
| Bowers Glenn R | Vice President of Breeding | Jun 15, 2018 | Sale | $19.49 | 423 | 8,244 | 8,617 | Jun 15, 2018, 06:11 PM |
| Choulika Andre | Director | Jun 15, 2018 | Sale | $19.49 | 2,352 | 45,840 | 154,448 | Jun 15, 2018, 02:38 PM |
| Cellectis S.A. | 10% Owner | Jun 15, 2018 | Buy | $19.49 | 63,175 | 1,231,281 | 22,713,175 | Jun 15, 2018, 02:19 PM |
| Voytas Daniel F | Chief Science Officer | May 21, 2018 | Option Exercise | $3.59 | 4,666 | 16,751 | 105,187 | May 23, 2018, 03:16 PM |
| Voytas Daniel F | Chief Science Officer | May 21, 2018 | Sale | $16.63 | 4,666 | 77,589 | 100,521 | May 23, 2018, 03:16 PM |
| Cellectis S.A. | 10% Owner | May 17, 2018 | Option Exercise | $15.00 | 550,000 | 8,250,000 | 22,650,000 | May 21, 2018, 04:31 PM |
| Voytas Daniel F | Chief Science Officer | May 08, 2018 | Option Exercise | $3.71 | 4,083 | 15,165 | 104,604 | May 10, 2018, 06:09 PM |
| Voytas Daniel F | Chief Science Officer | May 08, 2018 | Sale | $15.58 | 4,083 | 63,596 | 100,521 | May 10, 2018, 06:09 PM |
| Voytas Daniel F | Chief Science Officer | Apr 20, 2018 | Option Exercise | $3.59 | 4,666 | 16,751 | 105,187 | Apr 24, 2018, 06:13 PM |
| Voytas Daniel F | Chief Science Officer | Apr 20, 2018 | Sale | $16.87 | 4,666 | 78,701 | 100,521 | Apr 24, 2018, 06:13 PM |
| Voytas Daniel F | Chief Science Officer | Apr 09, 2018 | Option Exercise | $3.71 | 4,083 | 15,165 | 104,604 | Apr 11, 2018, 07:47 PM |
| Voytas Daniel F | Chief Science Officer | Apr 09, 2018 | Sale | $14.38 | 4,083 | 58,734 | 100,521 | Apr 11, 2018, 07:47 PM |
| Voytas Daniel F | Chief Science Officer | Mar 20, 2018 | Option Exercise | $3.59 | 4,666 | 16,741 | 4,666 | Mar 22, 2018, 07:25 PM |
| Voytas Daniel F | Chief Science Officer | Mar 20, 2018 | Sale | $17.91 | 4,666 | 83,561 | 0 | Mar 22, 2018, 07:25 PM |
| Voytas Daniel F | Chief Science Officer | Mar 08, 2018 | Sale | $18.10 | 4,083 | 73,914 | 0 | Mar 13, 2018, 06:25 PM |
| Godard Alain | Director | Mar 09, 2018 | Option Exercise | $3.59 | 10,000 | 35,875 | 49,200 | Mar 13, 2018, 06:22 PM |
| Godard Alain | Director | Mar 05, 2018 | Option Exercise | $3.59 | 10,000 | 35,875 | 49,200 | Mar 13, 2018, 06:22 PM |
| Godard Alain | Director | Mar 12, 2018 | Option Exercise | $3.59 | 10,000 | 35,878 | 49,200 | Mar 13, 2018, 06:22 PM |
| Godard Alain | Director | Mar 09, 2018 | Sale | $19.00 | 10,000 | 190,000 | 39,200 | Mar 13, 2018, 06:22 PM |
| Godard Alain | Director | Mar 05, 2018 | Sale | $19.00 | 10,000 | 190,000 | 39,200 | Mar 13, 2018, 06:22 PM |
| Godard Alain | Director | Mar 12, 2018 | Sale | $19.00 | 10,000 | 190,000 | 39,200 | Mar 13, 2018, 06:22 PM |
| Arbadji Michel | Director of Business Developme | Feb 28, 2018 | Option Exercise | $3.59 | 3,500 | 12,557 | 32,900 | Mar 02, 2018, 02:02 PM |
| Arbadji Michel | Director of Business Developme | Feb 28, 2018 | Sale | $18.63 | 3,500 | 65,220 | 29,400 | Mar 02, 2018, 02:02 PM |
| Godard Alain | Director | Feb 26, 2018 | Option Exercise | $35.59 | 10,000 | 355,878 | 49,200 | Feb 28, 2018, 05:45 PM |
| Godard Alain | Director | Feb 26, 2018 | Sale | $19.03 | 10,000 | 190,262 | 39,200 | Feb 28, 2018, 05:45 PM |
| Godard Alain | Director | Feb 21, 2018 | Option Exercise | $3.58 | 13,700 | 49,046 | 52,900 | Feb 22, 2018, 06:09 PM |
| Godard Alain | Director | Feb 20, 2018 | Option Exercise | $3.71 | 6,125 | 22,724 | 45,325 | Feb 22, 2018, 06:09 PM |
| Godard Alain | Director | Feb 20, 2018 | Sale | $20.70 | 6,125 | 126,804 | 41,700 | Feb 22, 2018, 06:09 PM |
| Godard Alain | Director | Feb 22, 2018 | Sale | $19.00 | 400 | 7,600 | 39,200 | Feb 22, 2018, 06:09 PM |
| Godard Alain | Director | Feb 21, 2018 | Sale | $19.19 | 13,300 | 255,200 | 39,600 | Feb 22, 2018, 06:09 PM |
| Sahoo Manoj | Chief Commercial Officer | Feb 21, 2018 | Sale | $19.19 | 5,880 | 112,851 | 92,120 | Feb 22, 2018, 05:53 PM |
| Sahoo Manoj | Chief Commercial Officer | Feb 20, 2018 | Sale | $20.69 | 4,900 | 101,362 | 95,146 | Feb 22, 2018, 05:53 PM |
| Corkal Bryan W.J. | Chief Financial Officer | Feb 20, 2018 | Sale | $20.73 | 19,600 | 406,229 | 92,300 | Feb 22, 2018, 05:39 PM |
| Dumont Philippe | Director | Jul 25, 2017 | Buy | $8.00 | 400 | 3,200 | 20,000 | Jul 27, 2017, 09:52 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Gocal Gregory Francis William | Chief Scientific Officer & EVP | 07/15/2024 | 20,023 |
| Gocal Gregory Francis William | Chief Scientific Officer & EVP | 07/12/2024 | 20,000 |
| Gocal Gregory Francis William | Chief Scientific Officer & EVP | 06/27/2024 | 20,000 |
| RIGGS RORY B | Chief Executive Officer | 06/11/2024 | 1,000,008 |
| RIGGS RORY B | Chief Executive Officer | 12/12/2023 | 5,470,992 |
| RIGGS RORY B | Chief Executive Officer | 06/01/2023 | 31,500 |
| Koschak William | Chief Financial Officer | 03/27/2023 | 4,069 |
| Frimerman Debra H | General Counsel and Secretary | 03/27/2023 | 4,069 |
| Frey Travis | Chief Technology Officer | 03/27/2023 | 4,069 |
| Carr Michael A. | President and CEO | 03/27/2023 | 5,449 |
| Frimerman Debra H | General Counsel and Secretary | 03/14/2023 | 813 |
| Koschak William | Chief Financial Officer | 03/14/2023 | 770 |
| Frey Travis | Chief Technology Officer | 03/14/2023 | 706 |
| Carr Michael A. | President and CEO | 03/07/2023 | 8,714 |
| Frey Travis | Chief Technology Officer | 03/07/2023 | 5,147 |
| Frimerman Debra H | General Counsel and Secretary | 03/07/2023 | 5,147 |
| Koschak William | Chief Financial Officer | 03/07/2023 | 5,147 |
| Carr Michael A. | President and CEO | 01/01/2023 | 7,062 |
| Frey Travis | Chief Technology Officer | 01/01/2023 | 5,542 |
| Frimerman Debra H | General Counsel and Secretary | 01/01/2023 | 5,269 |
| Koschak William | Chief Financial Officer | 01/01/2023 | 6,279 |
| Ribeill Yves J | Director | 09/19/2022 | 7,173 |
| Carr Michael A. | President and CEO | 07/27/2022 | 893 |
| Ribeill Yves J | Director | 03/21/2022 | 21,238 |
| Frey Travis | Chief Technology Officer | 03/14/2022 | 2,347 |
| Frimerman Debra H | General Counsel and Secretary | 03/14/2022 | 2,702 |
| Koschak William | Chief Financial Officer | 03/14/2022 | 2,740 |
| Carr Michael A. | President and CEO | 08/30/2021 | 39,776 |
| Koschak William | Chief Financial Officer | 08/19/2021 | 64,112 |
| Ribeill Yves J | Executive Chair | 07/27/2021 | 184,066 |
| Carr Michael A. | President and CEO | 07/27/2021 | 182,500 |
| Ribeill Yves J | Executive Chair | 07/01/2021 | 49,035 |
| Dumont Philippe | Director | 07/18/2019 | 7,060 |
| Voytas Daniel F | Chief Science Officer | 01/04/2021 | 10,388 |
| Blome James | Chief Executive Officer | 12/31/2020 | 17,281 |
| Voytas Daniel F | Chief Science Officer | 12/18/2020 | 23,874 |
| Frey Travis | Chief Technology Officer | 12/01/2020 | 569 |
| Frey Travis | Chief Technology Officer | 11/02/2020 | 489 |
| Cellectis S.A. | 10% Owner | 10/16/2020 | 5,000,000 |
| Frey Travis | Chief Technology Officer | 10/01/2020 | 820 |
| Blome James | Chief Executive Officer | 09/30/2020 | 23,124 |
| Dumont Philippe | Director | 09/10/2020 | 17,729 |
| Frey Travis | Chief Technology Officer | 09/01/2020 | 811 |
| Kozicz-Stankiewicz Anna Ewa | Director | 07/02/2020 | 1,151 |
| Kozicz-Stankiewicz Anna Ewa | Director | 04/02/2020 | 703 |
| Dumont Philippe | Director | 08/14/2020 | 14,970 |
| Dumont Philippe | Director | 07/02/2020 | 1,109 |
| Dumont Philippe | Director | 04/02/2020 | 677 |
| Choulika Andre | Director | 07/01/2020 | 19,647 |
| Frey Travis | Chief Technology Officer | 08/03/2020 | 654 |
| Blome James | Chief Executive Officer | 07/01/2020 | 16,268 |
| Blome James | Chief Executive Officer | 06/29/2020 | 14,532 |
| Frey Travis | Chief Technology Officer | 07/01/2020 | 786 |
| Frey Travis | Chief Technology Officer | 06/01/2020 | 638 |
| Frey Travis | Chief Technology Officer | 05/01/2020 | 755 |
| Choulika Andre | Director | 03/31/2020 | 10,903 |
| Blome James | Chief Executive Officer | 03/31/2020 | 9,389 |
| Frey Travis | Chief Technology Officer | 04/01/2020 | 559 |
| Frey Travis | Chief Technology Officer | 03/02/2020 | 1,286 |
| Ribeill Yves J | Director | 02/28/2020 | 54,520 |
| Frey Travis | Chief Technology Officer | 02/03/2020 | 1,122 |
| Frey Travis | Chief Technology Officer | 01/15/2020 | 2,170 |
| Frey Travis | Chief Technology Officer | 01/14/2020 | 1,990 |
| Frey Travis | Chief Technology Officer | 01/13/2020 | 1,977 |
| Frey Travis | Chief Technology Officer | 01/10/2020 | 2,101 |
| Dumont Philippe | Director | 01/03/2020 | 1,794 |
| Kozicz-Stankiewicz Anna Ewa | Director | 01/03/2020 | 1,874 |
| Dumont Philippe | Director | 10/02/2019 | 1,171 |
| Kozicz-Stankiewicz Anna Ewa | Director | 10/02/2019 | 1,215 |
| Kozicz-Stankiewicz Anna Ewa | Director | 07/18/2019 | 7,350 |
| Dumont Philippe | Director | 07/18/2019 | 7,060 |
| Sahoo Manoj | Chief Commercial Officer | 07/01/2019 | 18,967 |
| Choulika Andre | Director | 06/14/2019 | 202,723 |
| Voytas Daniel F | Chief Science Officer | 04/29/2019 | 13,462 |
| Voytas Daniel F | Chief Science Officer | 04/29/2019 | 61,152 |
| Blome James | Chief Executive Officer | 04/02/2019 | 42,982 |
| Sahoo Manoj | Chief Commercial Officer | 04/01/2019 | 26,378 |
| Blome James | Chief Executive Officer | 03/26/2019 | 46,129 |
| Sahoo Manoj | Chief Commercial Officer | 03/20/2019 | 58,716 |
| Sahoo Manoj | Chief Commercial Officer | 03/19/2019 | 91,224 |
| Blome James | Chief Executive Officer | 03/19/2019 | 44,713 |
| Blome James | Chief Executive Officer | 03/12/2019 | 42,802 |
| Ribeill Yves J | Director | 03/14/2019 | 81,317 |
| Ribeill Yves J | Director | 03/13/2019 | 80,410 |
| Ribeill Yves J | Director | 03/12/2019 | 83,819 |
| Ribeill Yves J | Director | 03/11/2019 | 86,958 |
| Voytas Daniel F | Chief Science Officer | 02/25/2019 | 14,277 |
| Voytas Daniel F | Chief Science Officer | 02/25/2019 | 63,632 |
| Voytas Daniel F | Chief Science Officer | 02/01/2019 | 15,180 |
| Voytas Daniel F | Chief Science Officer | 01/31/2019 | 15,165 |
| Voytas Daniel F | Chief Science Officer | 02/01/2019 | 53,131 |
| Voytas Daniel F | Chief Science Officer | 01/31/2019 | 53,079 |
| Dumont Philippe | Director | 01/04/2019 | 13,404 |
| Sahoo Manoj | Chief Commercial Officer | 01/02/2019 | 25,389 |
| Voytas Daniel F | Chief Science Officer | 12/18/2018 | 15,165 |
| Voytas Daniel F | Chief Science Officer | 12/18/2018 | 53,079 |
| Voytas Daniel F | Chief Science Officer | 11/08/2018 | 15,165 |
| Voytas Daniel F | Chief Science Officer | 11/08/2018 | 53,079 |
| Voytas Daniel F | Chief Science Officer | 10/09/2018 | 15,165 |
| Voytas Daniel F | Chief Science Officer | 10/09/2018 | 56,514 |
| Dumont Philippe | Director | 10/05/2018 | 15,765 |
| Sahoo Manoj | Chief Commercial Officer | 10/01/2018 | 37,416 |
| Voytas Daniel F | Chief Science Officer | 09/20/2018 | 16,751 |
| Voytas Daniel F | Chief Science Officer | 09/20/2018 | 74,656 |
| Voytas Daniel F | Chief Science Officer | 08/20/2018 | 16,751 |
| Voytas Daniel F | Chief Science Officer | 08/20/2018 | 80,768 |
| Voytas Daniel F | Chief Science Officer | 08/08/2018 | 15,165 |
| Voytas Daniel F | Chief Science Officer | 08/08/2018 | 71,372 |
| Voytas Daniel F | Chief Science Officer | 07/20/2018 | 16,751 |
| Voytas Daniel F | Chief Science Officer | 07/20/2018 | 83,708 |
| Voytas Daniel F | Chief Science Officer | 07/20/2018 | 16,751 |
| Voytas Daniel F | Chief Science Officer | 07/20/2018 | 83,708 |
| Voytas Daniel F | Chief Science Officer | 07/09/2018 | 15,165 |
| Voytas Daniel F | Chief Science Officer | 07/09/2018 | 72,822 |
| Godard Alain | Director | 06/21/2018 | 122,540 |
| Voytas Daniel F | Chief Science Officer | 06/20/2018 | 16,751 |
| Voytas Daniel F | Chief Science Officer | 06/20/2018 | 95,910 |
| Arbadji Michel | Director of Business Developme | 06/20/2018 | 23,321 |
| Arbadji Michel | Director of Business Developme | 06/20/2018 | 143,000 |
| Sahoo Manoj | Chief Commercial Officer | 06/18/2018 | 10,050 |
| Corkal Bryan W.J. | Chief Financial Officer | 06/15/2018 | 95,613 |
| Arbadji Michel | Director of Business Developme | 06/15/2018 | 82,706 |
| Voytas Daniel F | Chief Science Officer | 06/15/2018 | 146,935 |
| Tripodi Federico A. | Chief Executive Officer | 06/15/2018 | 286,503 |
| Sahoo Manoj | Chief Commercial Officer | 06/15/2018 | 99,321 |
| Kozicz-Stankiewicz Anna Ewa | Director | 06/15/2018 | 19,490 |
| Dumont Philippe | Director | 06/15/2018 | 13,760 |
| Bowers Glenn R | Vice President of Breeding | 06/15/2018 | 8,244 |
| Choulika Andre | Director | 06/15/2018 | 45,840 |
| Cellectis S.A. | 10% Owner | 06/15/2018 | 1,231,281 |
| Voytas Daniel F | Chief Science Officer | 05/21/2018 | 16,751 |
| Voytas Daniel F | Chief Science Officer | 05/21/2018 | 77,589 |
| Cellectis S.A. | 10% Owner | 05/17/2018 | 8,250,000 |
| Voytas Daniel F | Chief Science Officer | 05/08/2018 | 15,165 |
| Voytas Daniel F | Chief Science Officer | 05/08/2018 | 63,596 |
| Voytas Daniel F | Chief Science Officer | 04/20/2018 | 16,751 |
| Voytas Daniel F | Chief Science Officer | 04/20/2018 | 78,701 |
| Voytas Daniel F | Chief Science Officer | 04/09/2018 | 15,165 |
| Voytas Daniel F | Chief Science Officer | 04/09/2018 | 58,734 |
| Voytas Daniel F | Chief Science Officer | 03/20/2018 | 16,741 |
| Voytas Daniel F | Chief Science Officer | 03/20/2018 | 83,561 |
| Voytas Daniel F | Chief Science Officer | 03/08/2018 | 73,914 |
| Godard Alain | Director | 03/09/2018 | 35,875 |
| Godard Alain | Director | 03/05/2018 | 35,875 |
| Godard Alain | Director | 03/12/2018 | 35,878 |
| Godard Alain | Director | 03/09/2018 | 190,000 |
| Godard Alain | Director | 03/05/2018 | 190,000 |
| Godard Alain | Director | 03/12/2018 | 190,000 |
| Arbadji Michel | Director of Business Developme | 02/28/2018 | 12,557 |
| Arbadji Michel | Director of Business Developme | 02/28/2018 | 65,220 |
| Godard Alain | Director | 02/26/2018 | 355,878 |
| Godard Alain | Director | 02/26/2018 | 190,262 |
| Godard Alain | Director | 02/21/2018 | 49,046 |
| Godard Alain | Director | 02/20/2018 | 22,724 |
| Godard Alain | Director | 02/20/2018 | 126,804 |
| Godard Alain | Director | 02/22/2018 | 7,600 |
| Godard Alain | Director | 02/21/2018 | 255,200 |
| Sahoo Manoj | Chief Commercial Officer | 02/21/2018 | 112,851 |
| Sahoo Manoj | Chief Commercial Officer | 02/20/2018 | 101,362 |
| Corkal Bryan W.J. | Chief Financial Officer | 02/20/2018 | 406,229 |
| Dumont Philippe | Director | 07/25/2017 | 3,200 |
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR CALYXT, INC.
STOCK BUYBACKS FOR CALYXT, INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Period of Report: 03/31/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
25.37%
2Q
BUYBACK ANNOUNCEMENT(S) FOR CALYXT, INC.
LOADING...